ETHZilla Corporation Warrant (ATNFW) Research

180 Life Sciences Corp. is a biotechnology firm currently in the clinical trial phase, dedicated to pioneering novel pharmaceutical treatments that address significant unmet medical needs in areas such as inflammatory conditions, fibrotic disorders, and pain management. This research and development effort is powered by the collective expertise of distinguished therapeutics specialists from Oxford University, the Hebrew University, and Stanford University. The company was co-founded by Marc Feldmann, Lawrence J. Steinman, and Jonathan B. Rothbard on September 7, 2016, and maintains its principal office in Palo Alto, California.

Market snapshot

Symbol
ATNFW
Price
$0.43
Day change
-6.52%
Market cap
$73.4M
P/E ratio
-0.21x
52-week range
0.36-0.4433
Sector
Healthcare
Industry
Medical - Pharmaceuticals

Peer companies

  • Aspira Women's Health Inc. (AWH)
  • Biophytis S.A. (BPTS)
  • Eiger BioPharmaceuticals, Inc. (EIGRQ)
  • Vyome Holdings, Inc. (HIND)
  • MedAvail Holdings, Inc. (MDVL)
  • Novan, Inc. (NOVN)
  • Notable Labs, Ltd. (NTBL)
  • PLx Pharma Inc. (PLXP)

Recent insider activity

  • Lomashuk Konstantin — trade (0 shares) on 2026-04-28
  • Lomashuk Konstantin — trade (1555573 shares) on 2026-04-28
  • Lomashuk Konstantin — trade (546433 shares) on 2026-04-28
  • Dalton Angela — A-Award (203562 shares) on 2026-04-02
  • Dalton Angela — trade (0 shares) on 2025-12-19

Open ETHZilla Corporation Warrant (ATNFW) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.